Trial intelligence / Profile preview

Verteporfin for Scar Prevention in Surgical Wounds

NCT06944249Phase 2Not yet recruiting

Start
May 2025
Primary completion
Apr 2026
Modality
Light/Condition-Responsive Prodrugs
01

Overview

A Phase 2 trial of verteporfin in scar. Planned start May 2025; status: not yet recruiting.

02

Drugs

verteporfin
03

Conditions

scar

Beyond the preview

Go deeper on NCT06944249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06944249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call